Louise Himmelstrup

Louise Himmelstrup has a diverse work experience in the pharmaceutical and regulatory affairs field. Louise is currently the Vice President of EU Regulatory Affairs at Zevra Therapeutics since June 2022. Prior to that, they worked at Orphazyme A/S from January 2018 to May 2022, holding various positions including Head of Global Regulatory Affairs and Senior Regulatory Lead. Louise also worked at LEO Pharma from November 2010 to December 2017, where they held the role of Senior Regulatory Project Manager and Regulatory Project Manager, among others. Before that, they gained experience at the Danish Medicines Agency as a Regulatory Coordinator and Pharmacist, and at Dalgas Boulevard Apotek and Roskilde Svane Apotek as a Pharmacist and Stud. Pharm. Louise's expertise lies in global regulatory strategies, project management, and leading regulatory focus teams.

From 2002 to 2008, Louise Himmelstrup attended the Faculty of Pharmaceutical Sciences at the University of Copenhagen. Louise received a degree in Cand. pharm.